Luminex has inked an agreement to acquire Nanosphere, in an all-cash transaction that equates to approximately $58 million.
Under the new agreement, Luminex will gain all outstanding shares for $1.35 per share in cash. The transaction is expected to be finalized by the second quarter.
Based in Northbrook, Ill., Nanosphere specializes in diagnostic tools for the early detection of respiratory, gastroenteric and bloodstream infections. — Anisa Jibrell